VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+15.01%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$115M
AUM Growth
+$115M
(+45%)
Cap. Flow
+$32.6M
Cap. Flow
% of AUM
28.25%
Top 10 Holdings %
Top 10 Hldgs %
16.88%
Holding
267
New
23
Increased
109
Reduced
60
Closed
21
Top Buys
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$1.4M |
| 2 |
Geron
GERN
|
$870K |
| 3 |
Iovance Biotherapeutics
IOVA
|
$856K |
| 4 |
iShares MSCI India ETF
INDA
|
$838K |
| 5 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
$759K |
Top Sells
| 1 |
ProShares Ultra Utilities
UPW
|
$1.12M |
| 2 |
Vanguard Energy ETF
VDE
|
$721K |
| 3 |
RXDX
Ignyta, Inc.
RXDX
|
$612K |
| 4 |
Fidelity MSCI Information Technology Index ETF
FTEC
|
$421K |
| 5 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$359K |
Sector Composition
| 1 | Healthcare | 78.8% |
| 2 | Financials | 0.81% |
| 3 | Technology | 0.52% |
| 4 | Consumer Discretionary | 0.44% |
| 5 | Communication Services | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares 20+ Year Treasury Bond ETF
TLT
$47.8B
| $3.32M | 2.88% | 27,200 +11,511 | +73% | +$1.4M |
|
|
2
Fidelity MSCI Information Technology Index ETF
FTEC
$15.1B
| $3.22M | 2.79% | 62,005 -8,112 | -12% | -$421K |
|
3
Vanguard Utilities ETF
VPU
$7.27B
| $2.55M | 2.22% | 22,845 -225 | -1% | -$25.2K |
|
|
4
Geron
GERN
$893M
| $1.61M | 1.4% | 379,430 +204,747 | +117% | +$870K |
|
5
Nektar Therapeutics
NKTR
$568M
| $1.6M | 1.38% | 15,011 -1,880 | -11% | -$200K |
|
|
6
Iovance Biotherapeutics
IOVA
$807M
| $1.54M | 1.33% | 90,926 +50,667 | +126% | +$856K |
|
7
Direxion Daily Financial Bull 3x Shares
FAS
$2.74B
| $1.52M | 1.31% | 23,570 +117 | +0.5% | +$7.52K |
|
|
GTHX
8
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.41M | 1.23% | 38,125 +20,478 | +116% | +$759K |
|
|
ONC
9
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $1.36M | 1.18% | 8,082 +4,349 | +117% | +$731K |
|
|
ONCE
10
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $1.33M | 1.16% | 20,024 -1,172 | -6% | -$78K |
|
|
MRTX
11
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.32M | 1.15% | 43,136 +23,350 | +118% | +$717K |
|
|
JNCE
12
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $1.32M | 1.14% | 58,867 +31,919 | +118% | +$714K |
|
13
TG Therapeutics
TGTX
$4.65B
| $1.28M | 1.11% | 89,920 +48,087 | +115% | +$683K |
|
14
PTC Therapeutics
PTCT
$3.92B
| $1.27M | 1.1% | 46,917 +25,165 | +116% | +$681K |
|
15
Enanta Pharmaceuticals
ENTA
$180M
| $1.26M | 1.1% | 15,613 -1,918 | -11% | -$155K |
|
|
MNTA
16
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $1.24M | 1.08% | 68,484 -4,063 | -6% | -$73.7K |
|
|
17
iShares MSCI India ETF
INDA
$9.17B
| $1.24M | 1.08% | 36,402 +24,558 | +207% | +$838K |
|
18
Sarepta Therapeutics
SRPT
$1.78B
| $1.22M | 1.06% | 16,409 -1,488 | -8% | -$110K |
|
|
CBAY
19
DELISTED
Cymabay Therapeutics
CBAY
| $1.21M | 1.05% | 93,317 +50,832 | +120% | +$660K |
|
20
Novavax
NVAX
$1.21B
| $1.19M | 1.03% | 564,544 +299,338 | +113% | +$629K |
|
|
IMGN
21
DELISTED
Immunogen Inc
IMGN
| $1.18M | 1.03% | 112,547 +58,570 | +109% | +$616K |
|
22
Agios Pharmaceuticals
AGIO
$2.19B
| $1.18M | 1.02% | 14,405 +7,781 | +117% | +$636K |
|
23
Madrigal Pharmaceuticals
MDGL
$9.76B
| $1.13M | 0.98% | 9,629 +5,247 | +120% | +$613K |
|
|
ARRY
24
DELISTED
Array Biopharma Inc
ARRY
| $1.12M | 0.97% | 68,763 +36,645 | +114% | +$598K |
|
25
Ligand Pharmaceuticals
LGND
$3.15B
| $1.12M | 0.97% | 6,771 -390 | -5% | -$64.4K |
|